{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:55:03Z","timestamp":1792706103900,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4485,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/labinvest.2010.111","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T11:46:50Z","timestamp":1275911210000},"page":"1517-1532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["PPAR-\u03b3 agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage"],"prefix":"10.1016","volume":"90","author":[{"given":"Pilar","family":"Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Gonz\u00e1lez-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L","family":"P\u00e9rez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Maldonado-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A","family":"S\u00e1nchez-Tomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ru\u00edz-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Selgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"S\u00e1nchez-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abelardo","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00f3pez-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2010.111_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1523-1755.1999.00264.x","article-title":"The peritoneal membrane in chronic peritoneal dialysis","volume":"55","author":"Krediet","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"10.1038\/labinvest.2010.111_bib2","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080002004S03","article-title":"Pathophysiology of peritoneal membrane failure","volume":"20","author":"Krediet","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1038\/labinvest.2010.111_bib3","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1038\/labinvest.2010.111_bib4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/089686080902902S03","article-title":"Intrinsic cells: mesothelial cells - central players in regulating inflammation and resolution","volume":"29","author":"Yung","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1038\/labinvest.2010.111_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1038\/labinvest.2010.111_bib7","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.2001.59780042.x","article-title":"Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties","volume":"78","author":"Plum","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/labinvest.2010.111_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0272-6386(12)80814-6","article-title":"Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study","volume":"23","author":"Selgas","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/labinvest.2010.111_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis","volume":"23","author":"Margetts","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1038\/labinvest.2010.111_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Y\u00e1\u00f1ez-Mo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2010.111_bib11","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1046\/j.1523-1755.2003.00861.x","article-title":"Myofibroblastic conversion of mesothelial cells","volume":"63","author":"Yang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/labinvest.2010.111_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00428-003-0963-3","article-title":"Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis","volume":"444","author":"Jim\u00e9nez-Heffernan","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1038\/labinvest.2010.111_bib13","first-page":"262","article-title":"Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients","volume":"6","author":"Aguilera","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/labinvest.2010.111_bib14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.ajkd.2005.08.011","article-title":"Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor","volume":"46","author":"Aroeira","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/labinvest.2010.111_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1681\/ASN.2008020211","article-title":"Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane","volume":"20","author":"Aroeira","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib16","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/sj.ki.5002598","article-title":"Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport","volume":"108","author":"Del Peso","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/labinvest.2010.111_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-2143(99)90113-0","article-title":"Peritoneal dialysis: diabetes of the peritoneal cavity","volume":"134","author":"Rosenberg","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1038\/labinvest.2010.111_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: The role of advanced glycation end products in progression and complications of diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2010.111_bib19","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.111_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature"},{"key":"10.1038\/labinvest.2010.111_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2010.111_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1038\/labinvest.2010.111_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.cellbio.20.012103.134432","article-title":"Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation","volume":"20","author":"Castrillo","year":"2004","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1038\/labinvest.2010.111_bib24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.111_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.2010.111_bib26","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4049\/jimmunol.178.5.2940","article-title":"Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis","volume":"178","author":"Hontecillas","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.111_bib27","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.4049\/jimmunol.178.7.4129","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms","volume":"178","author":"Wohlfert","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.111_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2005030257","article-title":"Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists","volume":"17","author":"Li","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/labinvest.2008.104","article-title":"PPAR-\u03b3 agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-\u03b2","volume":"89","author":"Kawai","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2010.111_bib30","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/ndt\/gfn157","article-title":"Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats","volume":"23","author":"Ko","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib31","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1093\/ndt\/gfp103","article-title":"Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus","volume":"24","author":"Toblli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib32","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","article-title":"Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetes nephropaty in patientes","volume":"54","author":"Pistrosch","year":"2005","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2010.111_bib33","first-page":"32","article-title":"Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model","volume":"24","author":"Bozkurt","year":"2008","journal-title":"Adv Perit Dial"},{"key":"10.1038\/labinvest.2010.111_bib34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1159\/000097081","article-title":"Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution","volume":"24","author":"Yao","year":"2006","journal-title":"Blood Purif"},{"key":"10.1038\/labinvest.2010.111_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/089686080902900218","article-title":"Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: structural and functional alterations of the peritoneal membrane","volume":"29","author":"Gonz\u00e1lez-Mateo","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1038\/labinvest.2010.111_bib36","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1681\/ASN.V12112442","article-title":"Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases","volume":"12","author":"Catalan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib37","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1097\/01.ASN.0000099383.57934.0E","article-title":"Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis","volume":"14","author":"Justo","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib38","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0006-2952(03)00488-X","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-gamma) ligands as bifunctional regulator of cell proliferation","volume":"66","author":"Na","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2010.111_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.vph.2009.06.004","article-title":"PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation","volume":"51","author":"Ren","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"10.1038\/labinvest.2010.111_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jcp.21730","article-title":"Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins","volume":"220","author":"Wu","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1038\/labinvest.2010.111_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2008.11.019","article-title":"Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells","volume":"257","author":"Kwon","year":"2009","journal-title":"Toxicology"},{"key":"10.1038\/labinvest.2010.111_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2008.10.023","article-title":"Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells","volume":"275","author":"Sun","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1038\/labinvest.2010.111_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tox.2007.10.019","article-title":"Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells","volume":"244","author":"Kwon","year":"2008","journal-title":"Toxicology"},{"key":"10.1038\/labinvest.2010.111_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1242\/dmm.001321","article-title":"Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK\/NF-kappaB\/Snail1 pathway","volume":"1","author":"Strippoli","year":"2008","journal-title":"Dis Model Mech"},{"key":"10.1038\/labinvest.2010.111_bib45","first-page":"295","article-title":"A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells","volume":"68","author":"Yao","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib46","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/ndt\/gfl271","article-title":"Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia","volume":"21","author":"De Vriese","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.2005020155","article-title":"Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products","volume":"17","author":"Schwenger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/labinvest.2010.111_bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.ki.5002016","article-title":"Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation","volume":"71","author":"Boulanger","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/labinvest.2010.111_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ndt\/gfn495","article-title":"Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats","volume":"24","author":"Hirahara","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib51","first-page":"426","article-title":"Glycated adducts induce mesothelial cell transdifferentiation: role of glucose and icodextrin dialysis solutions","volume":"21","author":"Conti","year":"2008","journal-title":"J Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.bjp.0706309","article-title":"Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells","volume":"146","author":"Nevado","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1038\/labinvest.2010.111_bib53","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/ndt\/gfh277","article-title":"The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products","volume":"19","author":"Boulanger","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib54","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.28.7.1547","article-title":"A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia","volume":"28","author":"Goldberg","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1038\/labinvest.2010.111_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000093517","article-title":"Adipokine signaling in the peritoneal dialysis patient","volume":"150","author":"Axelsson","year":"2006","journal-title":"Contrib Nephrol"},{"key":"10.1038\/labinvest.2010.111_bib56","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/sj.ki.5000409","article-title":"Leptin induces TGF-beta synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell","volume":"69","author":"Leung","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/labinvest.2010.111_bib57","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ndt\/gfl715","article-title":"Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis","volume":"22","author":"Yang","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/labinvest.2010.111_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2008.00711.x","article-title":"Diversity in the contribution of IL-10 to T-cell-mediated immune regulation","volume":"226","author":"Maynard","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1038\/labinvest.2010.111_bib59","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/intimm\/dxl088","article-title":"TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection","volume":"18","author":"Kapp","year":"2006","journal-title":"Int Immunol"},{"key":"10.1038\/labinvest.2010.111_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330802597821","article-title":"How safe is the use of thiazolidinediones in clinical practice?","volume":"8","author":"Rizos","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1038\/labinvest.2010.111_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2710.2008.00967.x","article-title":"Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients","volume":"33","author":"Aramwit","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1038\/labinvest.2010.111_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/eje.1.02134","article-title":"Peroxisome proliferator-activated receptor gamma agonists in renal disease","volume":"154","author":"Iglesias","year":"2006","journal-title":"Eur J Endocrinol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722028604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722028604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:53:01Z","timestamp":1758397981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722028604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0023683722028604"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2010.111","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR-\u03b3 agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2010.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}